Why is Immuneering (IMRX) Stock Up 24% Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Up nearly 25% in today's session on a fast track designation for a key pancreatic cancer drug candidate, IMRX stock is coming into focus.
The post Why is Immuneering (IMRX) Stock Up 24% Today? appeared first on InvestorPlace.
More From InvestorPlace